Koninklijke Philips (NYSE:PHG – Get Free Report) was upgraded by analysts at BNP Paribas from an “underperform” rating to a “neutral” rating in a report released on Tuesday, MarketBeat Ratings reports.
A number of other research firms have also recently commented on PHG. StockNews.com raised shares of Koninklijke Philips from a “buy” rating to a “strong-buy” rating in a research report on Thursday, February 8th. JPMorgan Chase & Co. upgraded Koninklijke Philips from an “underweight” rating to a “neutral” rating in a report on Tuesday, April 30th. Finally, UBS Group raised Koninklijke Philips from a “sell” rating to a “neutral” rating in a research report on Tuesday, April 30th. Three investment analysts have rated the stock with a hold rating, one has issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.00.
Get Our Latest Stock Analysis on Koninklijke Philips
Koninklijke Philips Price Performance
Hedge Funds Weigh In On Koninklijke Philips
Several hedge funds have recently made changes to their positions in the company. Principal Securities Inc. acquired a new position in shares of Koninklijke Philips in the fourth quarter valued at about $27,000. Allspring Global Investments Holdings LLC acquired a new position in Koninklijke Philips in the 1st quarter worth approximately $40,000. Fifth Third Bancorp raised its position in Koninklijke Philips by 34.4% during the 1st quarter. Fifth Third Bancorp now owns 3,008 shares of the technology company’s stock worth $60,000 after buying an additional 770 shares during the last quarter. Allworth Financial LP raised its position in Koninklijke Philips by 113.3% during the 3rd quarter. Allworth Financial LP now owns 3,242 shares of the technology company’s stock worth $65,000 after buying an additional 1,722 shares during the last quarter. Finally, Spire Wealth Management lifted its stake in Koninklijke Philips by 127.2% during the 3rd quarter. Spire Wealth Management now owns 3,446 shares of the technology company’s stock valued at $69,000 after acquiring an additional 1,929 shares during the period. 13.67% of the stock is owned by institutional investors and hedge funds.
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Further Reading
- Five stocks we like better than Koninklijke Philips
- Where to Find Earnings Call Transcripts
- Lucid’s Stock Price is Still in Reverse: New Lows Are Coming
- Why Are Stock Sectors Important to Successful Investing?
- Generac Powers Ahead on the Electrification Mega-Trend
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- PulteGroup Wins and Wins More on Interest Rate Cuts
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.